Breaking News

Almac Increases European Footprint

CDMO continues its global expansion as it secures new premises in Republic of Ireland

Craigavon-based global contract pharmaceutical development and manufacturing organization (CDMO), Almac Group, has secured new premises in Dundalk, County Louth to support its ongoing global expansion plans in response to increased client demand.

Almac will make a multimillion-pound investment in the new facility at IDA Business Park, which will be utilized by Almac Pharma Services and Almac Clinical Services, both of which are registered to operate in the Republic of Ireland. The new site increases the group’s European footprint by 32,000 sq. ft. and provides continued presence within the EU for the long-term.

This investment comes just weeks after Almac confirmed plans to expand its operations at its global headquarters in Northern Ireland with the construction of a new laboratory and additional office facilities. The company simultaneously announced investment at its North American site creating an additional 300 new, full time jobs. These investments will see an increase of Almac’s global headcount to over 5,000 by the end of 2017.

“This latest investment in Dundalk is a further example of Almac’s ambitious global expansion plans and will deliver up to an additional 100 new jobs within the first two years,” said Alan Armstrong, chief executive officer, Almac Group. “This news comes in addition to our recent announcement of a £27 million investment at our global headquarter site in Craigavon, our U.S. operations and our European facility in Athlone. All of this is evidence of Almac’s commitment to provide best-in-class products and services to our clients across the world and we would like to thank all those who have supported us to date.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters